rxstat › Classes › Other Beta-lactam Antibacterials
Other Beta-lactam Antibacterials: shortage status in Canada
9 of the 14 other beta-lactam antibacterials rxstat tracks are currently in shortage in Canada, including 1 designated Tier 3 (most serious) by Health Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.
Widespread shortageCefaclor5 of 5 reported products affectedWidespread shortageCefazolin1 of 13 reported products affectedWidespread shortageCefepime2 of 3 reported products affected · est. return May 29, 2026Partial shortageCefixime1 of 4 reported products affected · est. return Jul 10, 2026Partial shortageCefprozil1 of 16 reported products affectedPartial shortageCeftriaxone1 of 15 reported products affected · est. return Jun 15, 2026Partial shortageCefuroxime3 of 13 reported products affectedPartial shortageCephalexin2 of 20 reported products affected · est. return Jul 10, 2026Partial shortageMeropenem2 of 11 reported products affectedNo current shortageCefadroxilDiscontinuedCefotaxime0 of 2 reported products affectedNo current shortageCefoxitinNo current shortageCeftazidimeNo current shortageErtapenem
Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.